ATHE
Alterity Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · AU
$2.43
−7.25%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-54.8%
Return on equity
-50.9%
Return on assets
-66.2%
Return on invested capital
0.00x
Asset turnover
-$16.2M
Cash from operations
$1.43
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026